ELV Elevance Health Inc

Price (delayed)

$490.335

Market cap

$117.11B

P/E Ratio

19

Dividend/share

$5.12

EPS

$25.81

Enterprise value

$132.01B

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately ...

Highlights
The company's revenue rose by 14% YoY and by 2.8% QoQ
Elevance Health's EPS has increased by 14% YoY and by 2.2% QoQ
ELV's P/E is 15% above its 5-year quarterly average of 16.6 and 2.6% above its last 4 quarters average of 18.6
ELV's quick ratio is down by 9% year-on-year

Key stats

What are the main financial stats of ELV
Market
Shares outstanding
238.83M
Market cap
$117.11B
Enterprise value
$132.01B
Valuations
Price to earnings (P/E)
19
Price to book (P/B)
3.27
Price to sales (P/S)
0.77
EV/EBIT
14.89
EV/EBITDA
12.66
EV/Sales
0.86
Earnings
Revenue
$153.25B
EBIT
$8.87B
EBITDA
$10.43B
Free cash flow
$10.4B
Per share
EPS
$25.81
Free cash flow per share
$43.31
Book value per share
$149.96
Revenue per share
$638.53
TBVPS
$283.79
Balance sheet
Total assets
$103.03B
Total liabilities
$66.98B
Debt
$23.77B
Equity
$35.99B
Working capital
$14.32B
Liquidity
Debt to equity
0.66
Current ratio
1.35
Quick ratio
1.21
Net debt/EBITDA
1.43
Margins
EBITDA margin
6.8%
Gross margin
17.5%
Net margin
4.1%
Operating margin
5.8%
Efficiency
Return on assets
6.2%
Return on equity
17.3%
Return on invested capital
20.4%
Return on capital employed
14.4%
Return on sales
5.8%
Dividend
Dividend yield
1.04%
DPS
$5.12
Payout ratio
19.8%

ELV stock price

How has the Elevance Health stock price performed over time
Intraday
-0.45%
1 week
2.59%
1 month
-4.41%
1 year
10.91%
YTD
-4.41%
QTD
-4.41%

Financial performance

How have Elevance Health's revenue and profit performed over time
Revenue
$153.25B
Gross profit
$26.85B
Operating income
$8.85B
Net income
$6.21B
Gross margin
17.5%
Net margin
4.1%
The company's revenue rose by 14% YoY and by 2.8% QoQ
Elevance Health's net income has increased by 13% YoY
The operating income has grown by 12% YoY
ELV's gross profit is up by 10% year-on-year and by 3.1% since the previous quarter

Growth

What is Elevance Health's growth rate over time

Valuation

What is Elevance Health stock price valuation
P/E
19
P/B
3.27
P/S
0.77
EV/EBIT
14.89
EV/EBITDA
12.66
EV/Sales
0.86
ELV's P/E is 15% above its 5-year quarterly average of 16.6 and 2.6% above its last 4 quarters average of 18.6
Elevance Health's EPS has increased by 14% YoY and by 2.2% QoQ
ELV's price to book (P/B) is 31% higher than its 5-year quarterly average of 2.5 and 2.5% higher than its last 4 quarters average of 3.2
The company's revenue rose by 14% YoY and by 2.8% QoQ
ELV's P/S is 10% above its 5-year quarterly average of 0.7 but 3.8% below its last 4 quarters average of 0.8

Efficiency

How efficient is Elevance Health business performance
Elevance Health's ROIC has increased by 13% YoY and by 4.1% from the previous quarter
ELV's ROE is up by 8% YoY
Elevance Health's return on assets has increased by 5% YoY

Dividends

What is ELV's dividend history
DPS
$5.12
Dividend yield
1.04%
Payout ratio
19.8%
Recent dividends

Financial health

How did Elevance Health financials performed over time
The total assets is 54% higher than the total liabilities
ELV's quick ratio is down by 9% year-on-year
The current ratio fell by 9% YoY
Elevance Health's debt is 34% less than its equity
Elevance Health's debt has increased by 4.3% YoY
The debt to equity is up by 3.1% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.